Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.

Sylvia KotterbaThomas NeusserChristiane NorenbergPatrick BussfeldThomas GlaserMartin DörnerMarkus Schürks

Published in: BMC neurology (2018)

The study was registered at clinicaltrials.gov: NCT01766063 (registered December 7, 2012). Registered retrospectively (first patient enrolled December 6, 2012).

Keyphrases

sleep quality
depressive symptoms
physical activity
case report
dendritic cells
obstructive sleep apnea
immune response
newly diagnosed